P J Goodnick

Summary

Publications

  1. ncbi request reprint Bipolar depression: a review of randomised clinical trials
    Paul J Goodnick
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Carrier Clinic, POB 147, 252 CR 601, Belle Mead, NJ 08502, USA
    Expert Opin Pharmacother 8:13-21. 2007
  2. ncbi request reprint Mirtazapine in major depression with comorbid generalized anxiety disorder
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Fla 33136, USA
    J Clin Psychiatry 60:446-8. 1999
  3. ncbi request reprint Anticonvulsants in the treatment of bipolar mania
    Paul J Goodnick
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Carrier Clinic, PO Box 147, Belle Mead, NJ 08502, USA
    Expert Opin Pharmacother 7:401-10. 2006
  4. ncbi request reprint Higher than Physician's Desk Reference (US) doses on atypical antipsychotics
    Paul J Goodnick
    Department of Psychiatry and Behavioural Sciences, Carrier Clinic, UMDNJ Robert Wood Johnson School of Medicine, 252 CR 601, Belle Mead, NJ 08502, USA
    Expert Opin Drug Saf 4:653-68. 2005
  5. ncbi request reprint Aripiprazole: profile on efficacy and safety
    Paul J Goodnick
    D79, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 3:1773-81. 2002
  6. ncbi request reprint Antipsychotics: impact on prolactin levels
    Paul J Goodnick
    Department of Psychiatry and Behavioural Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 3:1381-91. 2002
  7. ncbi request reprint Psychotropic drugs and the ECG: focus on the QTc interval
    Paul J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, D79, 1400 NW 10 Avenue, Ste 304A, Miami, Florida 33162, USA
    Expert Opin Pharmacother 3:479-98. 2002
  8. ncbi request reprint Ziprasidone: profile on safety
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Mail Code D79, Miami, Florida 33136, USA
    Expert Opin Pharmacother 2:1655-62. 2001
  9. ncbi request reprint Antipsychotic medication: effects on regulation of glucose and lipids
    M M Kato
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 2:1571-82. 2001
  10. ncbi request reprint Vagus nerve stimulation in depression
    P J Goodnick
    University of Miami School of Medicine, FL 33136, USA
    Expert Opin Pharmacother 2:1061-3. 2001

Detail Information

Publications19

  1. ncbi request reprint Bipolar depression: a review of randomised clinical trials
    Paul J Goodnick
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Carrier Clinic, POB 147, 252 CR 601, Belle Mead, NJ 08502, USA
    Expert Opin Pharmacother 8:13-21. 2007
    ..All antidepressants present with some risk for induction of mania and/or cycle acceleration and are best used in combination with mood stablisers; greatest risk for destabilisation seems to be with venlafaxine...
  2. ncbi request reprint Mirtazapine in major depression with comorbid generalized anxiety disorder
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Fla 33136, USA
    J Clin Psychiatry 60:446-8. 1999
    ..Because of mirtazapine's early anxiolytic effects, the present study was undertaken as a preliminary investigation in patients with a diagnosis of major depression with comorbid GAD...
  3. ncbi request reprint Anticonvulsants in the treatment of bipolar mania
    Paul J Goodnick
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Carrier Clinic, PO Box 147, Belle Mead, NJ 08502, USA
    Expert Opin Pharmacother 7:401-10. 2006
    ..A review of the kinetics, side effects and complications of the antiepileptic drugs indicates that carbamazepine is useful, and has adverse event benefit over all other options. The potential of zonisamide awaits further testing...
  4. ncbi request reprint Higher than Physician's Desk Reference (US) doses on atypical antipsychotics
    Paul J Goodnick
    Department of Psychiatry and Behavioural Sciences, Carrier Clinic, UMDNJ Robert Wood Johnson School of Medicine, 252 CR 601, Belle Mead, NJ 08502, USA
    Expert Opin Drug Saf 4:653-68. 2005
    ..Reports above those doses are included, but either are insufficient in numbers or bring up questions on safety. In many situations, feared increase in adverse events were not magnified by use of higher doses...
  5. ncbi request reprint Aripiprazole: profile on efficacy and safety
    Paul J Goodnick
    D79, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 3:1773-81. 2002
    ..Finally, results also support the proposition that aripiprazole may lead to reductions in corrected QT interval and have minimal drug interactions...
  6. ncbi request reprint Antipsychotics: impact on prolactin levels
    Paul J Goodnick
    Department of Psychiatry and Behavioural Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 3:1381-91. 2002
    ..Most recently, aripiprazole, in early studies, appears to produce significant reductions in hPrl while maintaining therapeutic efficacy for psychosis...
  7. ncbi request reprint Psychotropic drugs and the ECG: focus on the QTc interval
    Paul J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, D79, 1400 NW 10 Avenue, Ste 304A, Miami, Florida 33162, USA
    Expert Opin Pharmacother 3:479-98. 2002
    ..What is available concerning lithium, the anticonvulsants and the benzodiazepines indicates little effect on the QTc, although there may be effects on other cardiovascular parameters...
  8. ncbi request reprint Ziprasidone: profile on safety
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Mail Code D79, Miami, Florida 33136, USA
    Expert Opin Pharmacother 2:1655-62. 2001
    ....
  9. ncbi request reprint Antipsychotic medication: effects on regulation of glucose and lipids
    M M Kato
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 2:1571-82. 2001
    ..Ziprasidone appears to be the antipsychotic with the most beneficial combination of effects: no weight gain, no change in glucose utilisation and reductions in cholesterol and serum triglycerides (TGs)...
  10. ncbi request reprint Vagus nerve stimulation in depression
    P J Goodnick
    University of Miami School of Medicine, FL 33136, USA
    Expert Opin Pharmacother 2:1061-3. 2001
    ..These results have led to approval of VNS for the treatment of resistant depression (unipolar or bipolar) in both Europe and Canada. Currently, a pivotal double-blind acute study is underway in the US...
  11. ncbi request reprint Treatment of depression in comorbid medical illness
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, D79, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 1:1367-84. 2000
    ....
  12. ncbi request reprint Summary from the 153rd meeting of the American Psychiatric Association. 13-18 May 2000, Chicago, Illinois, USA
    P J Goodnick
    University of Miami, Department of Psychiatry and Behavioural Sciences, Miami, FL, USA
    Expert Opin Pharmacother 1:1067-9. 2000
    ..The latest developments are typically those found in the New Research sections, which is where this summary will focus...
  13. ncbi request reprint Women's issues in mood disorders
    P J Goodnick
    Department of Psychiatry and Behavioural Sciences, University of Miami, School of Medicine, D79, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 1:903-16. 2000
    ....
  14. ncbi request reprint Seligiline transdermal system in depression
    Paul J Goodnick
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Carrier Clinic, POB 147, 252 CR 601, Belle Mead, NJ 08502, USA
    Expert Opin Pharmacother 8:59-64. 2007
    ..This is generally a time period of 1 week. Upon stopping treatment with selegiline, 2 weeks should pass prior to beginning any medication at risk for drug interactions...
  15. ncbi request reprint The use of nimodipine in the treatment of mood disorders
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, FL 33136, USA
    Bipolar Disord 2:165-73. 2000
    ..g., ultra-rapid-cycling bipolars and brief recurrent depressions...
  16. ncbi request reprint Use of olanzapine in non-psychotic psychiatric disorders
    P J Goodnick
    Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, D79, 1400 NW 10 Avenue, Miami, Florida 33136, USA
    Expert Opin Pharmacother 2:667-80. 2001
    ..In each of these latter diagnoses, double-blind studies are either underway or are planned to establish efficacy...
  17. ncbi request reprint Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy
    P J Goodnick
    Department of Psychiatry, University of Miami School of Medicine, Florida 33136, USA
    Ann Clin Psychiatry 13:31-41. 2001
    ..In diabetic neuropathy without depression, the best choices among non-TCAs may include sertraline, citalopram, and perhaps, venlafaxine, since the TCAs appear to increase cravings and increase FBG levels...
  18. ncbi request reprint Rapid cycling bipolar disorder
    C Barrios
    Department of Psychiatry and Behavioural Sciences, University of Miami School of Medicine, D79, 1400 NW 10 Avenue, Ste 304A, Miami, FL 33136, USA
    Expert Opin Pharmacother 2:1963-73. 2001
    ..More research is needed into the possible therapeutic benefits of verapamil, bupropion, choline, light therapy and electroconvulsive therapy (ECT)...
  19. ncbi request reprint The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication
    Alan J Gelenberg
    University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    J Clin Psychiatry 65:1114-9. 2004
    ..A continuation study of an extract of St. John's wort (Hypericum perforatum) for depression was performed in follow-up to an acute study that found no significant difference between St. John's wort extract and placebo...